JP Stock MarketDetailed Quotes

7120 Shinko

Watchlist

2014
+27+1.36%

20min DelayMarket Closed Dec 30 15:30 JST

3.69BMarket Cap8.99P/E (Static)

Shinko Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Mar 31, 2024

(Q4)Mar 31, 2024

(Q3)Dec 31, 2023

(Q2)Sep 30, 2023

(Q1)Jun 30, 2023

(FY)Mar 31, 2023

(Q4)Mar 31, 2023

Total revenue

1.23%16.15B

-6.48%4.89B

3.72B

3.93B

3.61B

15.95B

5.23B

Cost of revenue

0.85%12.42B

-8.79%3.79B

2.83B

3.05B

2.75B

12.32B

4.16B

Gross profit

2.53%3.72B

2.50%1.1B

889.04M

872.95M

865.07M

3.63B

1.07B

Operating expense

7.56%3.1B

-4.32%794.84M

765.91M

740.37M

795.74M

2.88B

830.69M

Operating profit

-16.69%627.16M

26.15%302.13M

123.13M

132.57M

69.33M

752.83M

239.5M

Net non-operating interest income (expenses)

13.50%-346K

80.71%-38K

-102K

-21K

-185K

-400K

-197K

Non-operating interest income

3.74%111K

5.66%56K

--0

----

--107K

--53K

Non-operating interest expense

-9.86%457K

-62.40%94K

--102K

--76K

--185K

--507K

--250K

Net investment income

Gain(Loss) on financial instruments designated as cash flow hedges

Gain(Loss) on derecognition of available-for-sale financial assets

Income from associates and other participating interests

Special income (charges)

-19.73%3.35M

181.97%682K

1.01M

929K

732K

4.17M

-832K

Less:Other special charges

44.06%-3.63M

35.13%-962K

---1.01M

---929K

---732K

---6.49M

---1.48M

Less:Write off

-87.90%280K

----

--2.32M

----

Other non-operating income (expenses)

31.77%4.62M

-51.58%718K

492K

2.62M

789K

3.5M

1.48M

Income before tax

-16.49%634.78M

26.48%303.49M

124.53M

136.1M

70.66M

760.1M

239.95M

Income tax

-19.52%224.16M

18.47%107.4M

43.06M

47.46M

26.24M

278.54M

90.66M

Net income

-14.73%410.62M

31.34%196.09M

81.46M

88.64M

44.43M

481.56M

149.3M

Net income continuous operations

-14.73%410.62M

31.34%196.09M

--81.46M

--88.64M

--44.43M

--481.56M

--149.3M

Noncontrolling interests

Net income attributable to the company

-14.73%410.62M

31.34%196.09M

81.46M

88.64M

44.43M

481.56M

149.3M

Preferred stock dividends

Other under preferred stock dividend

Net income attributable to common stockholders

-14.73%410.62M

31.34%196.09M

81.46M

88.64M

44.43M

481.56M

149.3M

Gross dividend payment

Basic earnings per share

-19.76%225.1

23.77%107.28

44.48

48.58

24.76

280.53

86.6764

Diluted earnings per share

-18.39%223.94

28.49%106.93

44.43

48.34

24.24

274.41

83.2207

Dividend per share

14.29%80

Currency Unit

JPY

Accounting Standards

NonUS-GAAP

	(FY)Mar 31, 2024	(Q4)Mar 31, 2024	(Q3)Dec 31, 2023	(Q2)Sep 30, 2023	(Q1)Jun 30, 2023	(FY)Mar 31, 2023	(Q4)Mar 31, 2023
Total revenue	1.23%16.15B	-6.48%4.89B	3.72B	3.93B	3.61B	15.95B	5.23B
Cost of revenue	0.85%12.42B	-8.79%3.79B	2.83B	3.05B	2.75B	12.32B	4.16B
Gross profit	2.53%3.72B	2.50%1.1B	889.04M	872.95M	865.07M	3.63B	1.07B
Operating expense	7.56%3.1B	-4.32%794.84M	765.91M	740.37M	795.74M	2.88B	830.69M
Operating profit	-16.69%627.16M	26.15%302.13M	123.13M	132.57M	69.33M	752.83M	239.5M
Net non-operating interest income (expenses)	13.50%-346K	80.71%-38K	-102K	-21K	-185K	-400K	-197K
Non-operating interest income	3.74%111K	5.66%56K	--0	----	----	--107K	--53K
Non-operating interest expense	-9.86%457K	-62.40%94K	--102K	--76K	--185K	--507K	--250K
Net investment income
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests
Special income (charges)	-19.73%3.35M	181.97%682K	1.01M	929K	732K	4.17M	-832K
Less:Other special charges	44.06%-3.63M	35.13%-962K	---1.01M	---929K	---732K	---6.49M	---1.48M
Less:Write off	-87.90%280K	----	----	----	----	--2.32M	----
Other non-operating income (expenses)	31.77%4.62M	-51.58%718K	492K	2.62M	789K	3.5M	1.48M
Income before tax	-16.49%634.78M	26.48%303.49M	124.53M	136.1M	70.66M	760.1M	239.95M
Income tax	-19.52%224.16M	18.47%107.4M	43.06M	47.46M	26.24M	278.54M	90.66M
Net income	-14.73%410.62M	31.34%196.09M	81.46M	88.64M	44.43M	481.56M	149.3M
Net income continuous operations	-14.73%410.62M	31.34%196.09M	--81.46M	--88.64M	--44.43M	--481.56M	--149.3M
Noncontrolling interests
Net income attributable to the company	-14.73%410.62M	31.34%196.09M	81.46M	88.64M	44.43M	481.56M	149.3M
Preferred stock dividends
Other under preferred stock dividend	0	0	0	0	0	0	0
Net income attributable to common stockholders	-14.73%410.62M	31.34%196.09M	81.46M	88.64M	44.43M	481.56M	149.3M
Gross dividend payment
Basic earnings per share	-19.76%225.1	23.77%107.28	44.48	48.58	24.76	280.53	86.6764
Diluted earnings per share	-18.39%223.94	28.49%106.93	44.43	48.34	24.24	274.41	83.2207
Dividend per share	14.29%80	14.29%80	0	0	0	70	70
Currency Unit	JPY	JPY	JPY	JPY	JPY	JPY	JPY
Accounting Standards	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP

Symbol Price % Chg

D. Western Therapeutics Institute

4576

201 +23.31%

See the daily top gainer.